BeatO, a comprehensive digital care platform for controlling and reversing Diabetes, founded by Gautam Chopra, Yash Sehgal and Kunal Kinalekar, has raises $33 million in Series B funding led by Lightrock India with participation from HealthQuad, Flipkart Ventures and existing investors.

Commenting on the new funding, Gautam Chopra, Co-Founder and CEO, BeatO said, “With our digital-first solution, BeatO is well positioned to lay the new standards of how care will be delivered in the future to millions of Indians. We are pleased to have a fantastic set of partners joining us on the journey who deeply resonate with our vision and bring solid capabilities to help us achieve our goal.”

Tejasvi Ravi, who leads healthcare investments at  Lightrock India added, “BeatO is on an ambitious mission to re-design how diabetes is cared for in India. They are a world-class team that have demonstrated the ability to deliver consistent, high-quality and empathetic care resulting in clinical outcomes that are outstanding.”

The fresh funds will be utilised to expand BeatO’s diabetes care programs pan-India, invest in strengthening their leadership team and to further invest in BeatO’s product and technology. BeatO will also continue to build the evidence base for its care programs, setting the standard of care globally for diabetes. BeatO aims to serve over 10 million patients by 2025, becoming India’s largest Diabetes Care Company.

Speaking on the investment, Ravi Iyer, Senior Vice President and Head - Corporate Development, at Flipkart, said, "Through this investment in BeatO, Flipkart ventures is committed to supporting a business that is building next-generation innovations and evolving the digital health ecosystem. BeatO, with its holistic, differentiated and affordable digital care solution, is well placed to address the rising diabetes epidemic in India.”

The Company’s existing marquee investors include Orios Venture Partners, Leo Capital, W Health Ventures, Blume Ventures and others.